Last checked at 9 Dec 2020 07:55
Ap19
FORM 8.3 Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 04 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
| |||
3,047,027 | 2.36% | 689,679 | 0.54% | ||
(2) | Derivatives (other than options): | ||||
365,554 | 0.28% | 739,005 | 0.57% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
| |||||
(4) | TOTAL: | ||||
3,412,581 | 2.65% | 1,428,684 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) | Purchases and sales |
|
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 213.8675 USD |
Purchase | 2 | 214.4250 USD |
Purchase | 4 | 213.8350 USD |
Purchase | 5 | 213.5000 USD |
Purchase | 7 | 213.8164 USD |
Purchase | 8 | 213.7325 USD |
Purchase | 8 | 213.8550 USD |
Purchase | 10 | 213.5605 USD |
Purchase | 10 | 213.5300 USD |
Purchase | 10 | 213.8725 USD |
Purchase | 12 | 212.7600 USD |
Purchase | 13 | 213.7669 USD |
Purchase | 16 | 213.3250 USD |
Purchase | 23 | 213.7695 USD |
Purchase | 35 | 213.9998 USD |
Purchase | 60 | 213.5650 USD |
Purchase | 81 | 214.9900 USD |
Purchase | 100 | 214.9300 USD |
Purchase | 100 | 215.2000 USD |
Purchase | 120 | 214.9800 USD |
Purchase | 127 | 213.8333 USD |
Purchase | 132 | 215.0633 USD |
Purchase | 140 | 215.0014 USD |
Purchase | 307 | 213.7090 USD |
Purchase | 400 | 215.2212 USD |
Purchase | 402 | 215.1631 USD |
Purchase | 907 | 214.1368 USD |
Purchase | 2,756 | 214.1286 USD |
Purchase | 2,862 | 214.7631 USD |
Purchase | 2,946 | 214.3183 USD |
Purchase | 3,819 | 214.1273 USD |
Purchase | 6,167 | 213.9558 USD |
Purchase | 11,036 | 214.2561 USD |
Purchase | 12,132 | 214.4900 USD |
Purchase | 80,920 | 214.4895 USD |
Purchase | 82,929 | 214.4719 USD |
Sale | 1 | 213.1600 USD |
Sale | 1 | 213.7900 USD |
Sale | 1 | 215.4025 USD |
Sale | 2 | 214.9100 USD |
Sale | 2 | 213.4900 USD |
Sale | 2 | 213.9550 USD |
Sale | 3 | 213.9300 USD |
Sale | 4 | 214.1300 USD |
Sale | 4 | 214.4750 USD |
Sale | 4 | 213.8912 USD |
Sale | 4 | 214.2300 USD |
Sale | 5 | 214.3060 USD |
Sale | 6 | 214.3233 USD |
Sale | 7 | 213.5842 USD |
Sale | 8 | 214.0206 USD |
Sale | 10 | 213.5300 USD |
Sale | 11 | 213.7645 USD |
Sale | 14 | 214.1485 USD |
Sale | 16 | 213.3250 USD |
Sale | 35 | 214.1902 USD |
Sale | 60 | 213.5650 USD |
Sale | 100 | 214.4400 USD |
Sale | 100 | 213.9400 USD |
Sale | 109 | 213.7600 USD |
Sale | 121 | 214.0013 USD |
Sale | 200 | 213.6700 USD |
Sale | 254 | 213.8333 USD |
Sale | 283 | 214.4661 USD |
Sale | 289 | 214.4799 USD |
Sale | 706 | 213.9897 USD |
Sale | 840 | 214.4774 USD |
Sale | 1,551 | 214.4151 USD |
Sale | 1,815 | 213.8676 USD |
Sale | 2,150 | 214.3133 USD |
Sale | 3,212 | 214.0158 USD |
Sale | 4,337 | 214.8834 USD |
Sale | 6,368 | 213.9778 USD |
Sale | 14,266 | 214.2240 USD |
Sale | 169,808 | 214.4900 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
unit | |||
SWAP | Long | 121,000 | 214.4900 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
| NONE | |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 9 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201208006227/en/
Copyright Business Wire 2020